Purchase Order 75D30121P12035
Award Date
7/21/21
Potential Completion Date
8/23/21
Potential Value
$206K
Federal Agency
CDC Pittsburgh
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions, for the provision of a NEXTSEQ 1000 Sequencing system. The $205,800.00 contract has a completion date of September 30, 2022 and was awarded on August 2, 2022. Illumina has previously received prime federal contracts from agencies such as the National Institutes of Health, Department of...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a 5-year, Firm Fixed Price purchase order valued at $211,080.73 to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The award is for maintenance services to support Illumina's sequencing platforms, such as NextSeq, NovaSeq, MiSeq, and iSeq, which are used across federal agencies including the NIH, CDC, USDA, and VA for research and diagnostics...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $22,376.85 contract is for the provision of an ISEQ 100 SYSTEM, with a completion date of March 1, 2026. This award does not have a set-aside designation. Illumina has previously received prime federal contracts from agencies such as the NIH,...
This federal contract award to Illumina, Inc. is for the purchase of a NEXTSEQ 1000 SEQ SYSTEM, a genetic sequencing instrument, by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, PA. The $159,600.00 firm fixed-price purchase order does not have a set-aside designation. Illumina is a manufacturer and provider of genetic and genomic analysis instruments and reagents, and has received previous prime contract awards from federal agencies like the NIH, USDA, and VA to support...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of a NextSeq sequencing system and has a ceiling value of $230,845.58. The contract has a period of performance ending on September 30, 2024. Illumina has previously been awarded prime contracts and subcontracts by various federal agencies, including the National Institutes...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, for ILLUMINA ISEQ 100 I1 REAGENT. The potential value of this contract is $9,991.97. This award is not associated with any larger contract vehicle and does not have a set-aside designation. Illumina has previously provided sequencing systems, reagents,...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for the provision of an ILLUMINA NS 1000 INSTRUMENT. The potential value of this award is $205,800.00. Illumina has previously received prime federal contract awards from various agencies like the NIH, CDC, USDA, and VA to provide a range of genomic sequencing systems, consumables, and...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $54,367.08 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for the repair/replacement and advanced support plan for ISEQ equipment, with performance to be completed by August 20, 2028. Illumina has previously provided sequencing systems, consumables, and services to support genomic research and...
This firm fixed price BPA call was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The $120,017.07 award is for Illumina's genomic sequencing solutions, including NextSeq, NovaSeq, MiSeq, and iSeq systems, to support the CDC's research and diagnostic needs. Illumina has previously provided sequencing platforms and services to other federal agencies...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Blanket Purchase Agreement (BPA) call to Illumina, Inc., a for-profit manufacturer of sequencing and array-based solutions, to provide a NOVASEQ 6000 SEQUENCING SYSTEM. The firm fixed-price contract, valued at $875,000.00, was awarded on August 29, 2019 with a completion date of October 30, 2019. Illumina has a history of providing various sequencing instruments, reagents, and services to support...